What Happened?
Durham, NC-based Opus-Genetics Appointed Jennifer Hunt as Chief Development Officer
About the Company
Opus Genetics is a groundbreaking gene therapy company for inherited retinal diseases with a unique model and purpose. Backed by Foundation Fighting Blindness`s venture arm, the RD Fund, Opus combines unparalleled insight and commitment to patient need with wholly owned programs in numerous orphan retinal diseases.
About the Person
Jennifer Hunt is Chief Development Officer at Opus Genetics. Previously, Jennifer held various senior HR leadership roles in the industry.
Info Source
News
Short Profile